{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:54:09Z","timestamp":1791082449630,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive disease caused by mutations in the RMRP gene. Beside dwarfism, CHH has a wide spectrum of clinical manifestations including variable grades of combined immunodeficiency, autoimmune complications, and malignancies. Previous reports in single CHH patients with significant immunodeficiencies have demonstrated that allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for the severe immunodeficiency, while growth failure remains unaffected. Because long-term experience in larger cohorts of CHH patients after HSCT is currently unreported, we performed a European collaborative survey reporting on 16 patients with CHH and immunodeficiency who underwent HSCT. Immune dysregulation, lymphoid malignancy, and autoimmunity were important features in this cohort. Thirteen patients were transplanted in early childhood (\u223c 2.5 years). The other 3 patients were transplanted at adolescent age. Of 16 patients, 10 (62.5%) were long-term survivors, with a median follow-up of 7 years. T-lymphocyte numbers and function have normalized, and autoimmunity has resolved in all survivors. HSCT should be considered in CHH patients with severe immunodeficiency\/autoimmunity, before the development of severe infections, major organ damage, or malignancy might jeopardize the outcome of HSCT and the quality of life in these patients.<\/jats:p>","DOI":"10.1182\/blood-2010-01-259168","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T22:30:49Z","timestamp":1270679449000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation"],"prefix":"10.1182","volume":"116","author":[{"given":"Victoria","family":"Bordon","sequence":"first","affiliation":[{"name":"Pediatric Hematology, Oncology and Stem Cell Transplantation, Kliniek voor Kinderziekten C. Hooft, Ghent University Hospital, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Vandecruys","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Stem Cell Transplantation, Kliniek voor Kinderziekten C. Hooft, Ghent University Hospital, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Laureys","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Stem Cell Transplantation, Kliniek voor Kinderziekten C. Hooft, Ghent University Hospital, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Departments of Bone Marrow Transplantation and Clinical Immunology, Great Ormond Street Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Qasim","sequence":"additional","affiliation":[{"name":"Departments of Bone Marrow Transplantation and Clinical Immunology, Great Ormond Street Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Universit\u00e4tskinderklinik und Poliklinik, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulfraat","sequence":"additional","affiliation":[{"name":"Utrecht University Hospital, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Scherer","sequence":"additional","affiliation":[{"name":"Division of Immunology\/Hematology\/BMT, University Children's Hospital, Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cant","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Necker-Enfants Malades, Service d'Immuno-H\u00e9matologie P\u00e9diatrique, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana-Calvo","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Necker-Enfants Malades, Service de Biotherapie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert G. M.","family":"Bredius","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[{"name":"The Manton Center for Orphan Disease Research and Division of Immunology, Children's Hospital, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Mazzolari","sequence":"additional","affiliation":[{"name":"Oncology-Haematology Unit, Clinica Pediatrica, Spedali Civili, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Necker-Enfants Malades, Service d'Immuno-H\u00e9matologie P\u00e9diatrique, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[{"name":"Division of Immunology\/Hematology\/BMT, University Children's Hospital, Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111800033003600_B1","first-page":"285","article-title":"Dwarfism in the Amish. II. Cartilage hair hypoplasia.","volume":"116","author":"McKusick","year":"1965","journal-title":"Bull John Hopkins Hosp"},{"issue":"9","key":"2019111800033003600_B2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jmg.29.9.652","article-title":"Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients.","volume":"29","author":"Makitie","year":"1992","journal-title":"J Med Genet"},{"issue":"2","key":"2019111800033003600_B3","first-page":"563","article-title":"Anemia in children with cartilage-hair hypoplasia is related to body growth and to the insulin-like growth factor system.","volume":"85","author":"Makitie","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019111800033003600_B4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","article-title":"Increased incidence of cancer in patients with cartilage-hair hypoplasia.","volume":"134","author":"Makitie","year":"1999","journal-title":"J Pediatr"},{"key":"2019111800033003600_B5","volume-title":"Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development","author":"Spranger","year":"2003","edition":"2nd edition"},{"issue":"7261","key":"2019111800033003600_B6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature08283","article-title":"An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.","volume":"461","author":"Maida","year":"2009","journal-title":"Nature"},{"issue":"2","key":"2019111800033003600_B7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1399-0004.2002.610210.x","article-title":"RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphism.","volume":"61","author":"Bonaf\u00e9","year":"2002","journal-title":"Clin Genet"},{"issue":"4","key":"2019111800033003600_B8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng0493-338","article-title":"Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis.","volume":"3","author":"Sulisalo","year":"1993","journal-title":"Nat Genet"},{"issue":"2","key":"2019111800033003600_B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0092-8674(01)00205-7","article-title":"Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia.","volume":"104","author":"Ridanpaa","year":"2001","journal-title":"Cell"},{"issue":"4","key":"2019111800033003600_B10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1371\/journal.pgen.0010047","article-title":"Evolutionary comparison provides evidence for pathogenicity of RMRP mutations.","volume":"1","author":"Bonaf\u00e9","year":"2005","journal-title":"PLoS Genet"},{"key":"2019111800033003600_B11","first-page":"A201","article-title":"Genetic and physical mapping of the cartilage-hair hypoplasia locus on 9p13 (abstract).","volume":"57","author":"Ridanpaa","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"23","key":"2019111800033003600_B12","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/hmg\/ddi403","article-title":"Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia.","volume":"14","author":"Hermanns","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"6824","key":"2019111800033003600_B13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/35065191","article-title":"A big development for a small RNA.","volume":"410","author":"Clayton","year":"2001","journal-title":"Nature"},{"issue":"5","key":"2019111800033003600_B14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/497708","article-title":"Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator.","volume":"77","author":"Thiel","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2019111800033003600_B15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s004310050943","article-title":"Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia.","volume":"157","author":"Makitie","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2019111800033003600_B16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mpd.2000.108102","article-title":"Deficiency of humoral immunity in cartilage-hair hypoplasia.","volume":"137","author":"Maikitie","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2019111800033003600_B17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01956147","article-title":"Cartilage-hair hypoplasia: clinical manifestations in 108 Finnish patients.","volume":"152","author":"M\u00e4kitie","year":"1993","journal-title":"Eur J Pediatr"},{"issue":"18","key":"2019111800033003600_B18","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma.","volume":"146A","author":"Taskinen","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2019111800033003600_B19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/adc.84.1.65","article-title":"Increased mortality in Cartilage-hair hypoplasia.","volume":"84","author":"M\u00e4kitie","year":"2001","journal-title":"Arch. Dis. Child"},{"key":"2019111800033003600_B20","first-page":"257","article-title":"Lymphoproliferative diseases associated with primary immune disorders.","volume-title":"World Health Organisation Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues","author":"Borisch","year":"2001"},{"issue":"2","key":"2019111800033003600_B21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2141.2002.03681.x","article-title":"Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry.","volume":"118","author":"Pinkerton","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111800033003600_B22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2008.07.036","article-title":"Variability of clinical and laboratory features among patients with ribonuclease mithocondrial RNA processing endoribonuclease gene mutations.","volume":"122","author":"Kavadas","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2019111800033003600_B23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.93.2.265","article-title":"Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency).","volume":"93","author":"Berthet","year":"1994","journal-title":"Pediatrics"},{"issue":"9357","key":"2019111800033003600_B24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haematopoietic stem cells for immunodeficiencies: report of the European experience, 1968-99.","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"2019111800033003600_B25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","article-title":"Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002.","volume":"103","author":"Gennery","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111800033003600_B26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease: report on a national registry of 368 patients.","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"issue":"13","key":"2019111800033003600_B27","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111800033003600_B28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","article-title":"Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.","volume":"97","author":"Filipovich","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2019111800033003600_B29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90127-G","article-title":"Methods of detection of new families with X-linked lymphoproliferative disease.","volume":"51","author":"Purtilo","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"issue":"7115","key":"2019111800033003600_B30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"issue":"2","key":"2019111800033003600_B31","first-page":"99","article-title":"Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.","volume":"36","author":"Lancaster","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111800033003600_B32","first-page":"1","article-title":"Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).","volume":"1","author":"Ehrlich","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2019111800033003600_B33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.mph.0000158257.45823.80","article-title":"Bone marrow transplantation for Nijmegen breakage syndrome.","volume":"27","author":"Gennery","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2019111800033003600_B34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bmt.1703844","article-title":"Non-myeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.","volume":"31","author":"Gungor","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111800033003600_B35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.","volume":"111","author":"Dupuis-Girod","year":"2003","journal-title":"Pediatrics"},{"issue":"4","key":"2019111800033003600_B36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02002714","article-title":"Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia.","volume":"155","author":"Berthet","year":"1996","journal-title":"Eur J Pediatr"},{"issue":"10","key":"2019111800033003600_B37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.40.10.761","article-title":"Short-limbed dwarfism with bowing, combined immune deficiency, and late onset aplastic anaemia caused by novel mutations in the RMPR gene.","volume":"40","author":"Kuijpers","year":"2003","journal-title":"J Med Genet"},{"issue":"11","key":"2019111800033003600_B38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705520","article-title":"Bone marrow transplantation for cartilage-hair-hypoplasia.","volume":"38","author":"Guggenheim","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111800033003600_B39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1203\/00006450-199202000-00018","article-title":"Growth in cartilage-hair hypoplasia.","volume":"31","author":"Makitie","year":"1992","journal-title":"Pediatr Res"},{"issue":"3","key":"2019111800033003600_B40","first-page":"621","article-title":"Lymphocyte dysfunction in cartilage hair hypoplasia: evidence for a cell cycle specific defect in T cell growth.","volume":"50","author":"Pierce","year":"1982","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2019111800033003600_B41","first-page":"570","article-title":"Lymphocyte dysfunction in cartilage hair hypoplasia: evidence for an intrinsic defect in cellular proliferation.","volume":"129","author":"Pierce","year":"1982","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2019111800033003600_B42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3083.1997.d01-112.x","article-title":"T cell subsets and T cell function in cartilage-hair hypoplasia.","volume":"46","author":"Kooijman","year":"1997","journal-title":"Scand J Immunol"},{"issue":"1","key":"2019111800033003600_B43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2009-03-211029","article-title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome.","volume":"114","author":"Poliani","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111800033003600_B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2007.01949.x","article-title":"Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.","volume":"66","author":"McLean-Tooke","year":"2007","journal-title":"Scand J Immunol"},{"issue":"6","key":"2019111800033003600_B45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ACI.0b013e328310fe7d","article-title":"Cartilage-hair hypoplasia: molecular and heterogeneity of the immunological phenotype.","volume":"8","author":"Notarangelo","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"2019111800033003600_B46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/014107688607900216","article-title":"Cartilage hair hypoplasia with thrombocytopenic purpura, autoimmune haemolytic anaemia and cell-mediated immunodeficiency.","volume":"79","author":"Ashby","year":"1986","journal-title":"J R Soc Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/1\/27\/1327447\/zh802710000027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/1\/27\/1327447\/zh802710000027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:58:06Z","timestamp":1685545086000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/116\/1\/27\/27366\/Clinical-and-immunologic-outcome-of-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-01-259168","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,8]]}}}